CA 15-3 Clinical Trials

• Stem Cell Transplantation for Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00001880 - Recruiting
  Cholangiocarcinoma; Colon/Rectal Ca; Bladder Ca; Breast Ca; Basal Cell Ca; Adrenal Ca; Esophageal/Gastric Ca; Hepatocellular Ca; Ovarian Ca; ...
  
• Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA
  ClinicalTrials.gov Identifier: NCT00535795 - Active, not recruiting
  Nasopharyngeal CA
  
• Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00110279 - Active, not recruiting
  Influenza; Virus Diseases
  
• Hormonal Ablation, Imatinib & Docetaxel Followed by Radical Prostatectomy for High-Risk Localized Prostate Ca.
  ClinicalTrials.gov Identifier: NCT00500110 - Active, not recruiting
  Prostate Cancer
  
• Pilot Trial of Pre-Operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA
  ClinicalTrials.gov Identifier: NCT00535041 - Active, not recruiting
  Rectal Neoplasms
  
• Molecular Profiling Protocol (SCRI-CA-001)
  ClinicalTrials.gov Identifier: NCT00530192 - Recruiting
  Refractory Cancer
  
• The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc 15 Setting
  ClinicalTrials.gov Identifier: NCT00467896 - Recruiting
  Pulmonary Hypertension
  
• Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA
  ClinicalTrials.gov Identifier: NCT00534729 - Active, not recruiting
  Laryngeal Neoplasms; Hypopharyngeal Neoplasms
  
• A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection
  ClinicalTrials.gov Identifier: NCT00560599 - Recruiting
  Methicillin Resistant Staphylococcus Aureus Skin Infections
  
• Luteal v. Follicular Phase Surgical Oophorectomy & Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor + Br. CA
  ClinicalTrials.gov Identifier: NCT00293540 - Recruiting
  Breast Cancer
  
• Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic CA
  ClinicalTrials.gov Identifier: NCT00547144 - Recruiting
  Pancreatic Cancer
  
• Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients
  ClinicalTrials.gov Identifier: NCT00563173 - Recruiting
  Chronic Hepatitis C Virus Infection
  
• QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT
  ClinicalTrials.gov Identifier: NCT00568425 - Recruiting
  Anal Cancer
  
• Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for Treatment of Mild Asthma in Children (4 to 11 y) (BY9010/CA-101)
  ClinicalTrials.gov Identifier: NCT00163293 - Recruiting
  Asthma
  
• CA 125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00058032 - Active, not recruiting
  ovarian epithelial cancer
  
• Depo-Provera: Evaluation of BMDensity and Total Body Ca Adolescent DP150CI Users and Non-Hormonal Contraception
  ClinicalTrials.gov Identifier: NCT00139685 - Active, not recruiting
  Contraception; Bone Density
  
• Quaternium-15, Use Test
  ClinicalTrials.gov Identifier: NCT00311454 - Not yet recruiting
  Allergic Contact Dermatitis Towards Quaternium-15
  
• A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-Based P Binders in Patients With Hyperphosphatemia
  ClinicalTrials.gov Identifier: NCT00451295 - Recruiting
  Chronic Kidney Disease; Dialysis; Hyperphosphatemia
  
• Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®
  ClinicalTrials.gov Identifier: NCT00269477 - Active, not recruiting
  Meningitis; Meningococcal Infection
  
• A Randomized, Controlled Study on Ca Blocker Vs. AII Antagonists in Hypertension with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00144144 - Active, not recruiting
  Hypertension; Diabetes Mellitus, Type 2
  
• Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults. The ACCEPT-Study. (BY9010/CA-102)
  ClinicalTrials.gov Identifier: NCT00404547 - Recruiting
  Asthma
  
• TPF+Radiation+/-Cetuximab in Larynx CA/ DeLOS II
  ClinicalTrials.gov Identifier: NCT00508664 - Recruiting
  Squamous Cell Carcinoma of the Hypopharynx; Larynx Carcinoma
  
• Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
  ClinicalTrials.gov Identifier: NCT00539162 - Recruiting
  Ovarian Cancer
  
• CA-125 in Screening Patients at High Risk for Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00080639 - Active, not recruiting
  ovarian epithelial cancer
  
• Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age
  ClinicalTrials.gov Identifier: NCT00492544 - Active, not recruiting
  Papillomavirus Infections; Cervical Cancer
  
• LT FU Studies at Y6,7 8,9,10: 2 Formulations of Combined hepatitisA/B Vaccine Compared in Subjects Aged 12-15 y
  ClinicalTrials.gov Identifier: NCT00197119 - Active, not recruiting
  Hepatitis A; Hepatitis B
  
• Immuno & Safety Study of GSK Biologicals’ Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs
  ClinicalTrials.gov Identifier: NCT00343915 - Active, not recruiting
  Prophylaxis of Hepatitis B
  
• Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA
  ClinicalTrials.gov Identifier: NCT00373711 - Recruiting
  Thyroid Cancer
  
• Comparison of Cephalexin Versus Clindamycin for Empiric Treatment of Suspected CA-MRSA Skin Infections
  ClinicalTrials.gov Identifier: NCT00352612 - Recruiting
  Staphylococcal Infection; Abscess; Staphylococcal Skin Infection; Folliculitis
  
• Computed Tomography and Serum CA-125 in Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00502151 - Recruiting
  Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
  
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 15 - 25 Years of Age
  ClinicalTrials.gov Identifier: NCT00552279 - Active, not recruiting
  HPV-16/18 Infections and Cervical Neoplasia
  
• A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis
  ClinicalTrials.gov Identifier: NCT00245479 - Active, not recruiting
  Nocturnal Enuresis
  
• Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACWY at 24 to 30 m in Primed Subjects
  ClinicalTrials.gov Identifier: NCT00317109 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Infections; Meningococcal Infections
  
• A 15-Day Study to Assess the Safety and Clinical Utility of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Continuous Pain Requiring Narcotic Pain Relief Therapy
  ClinicalTrials.gov Identifier: NCT00271414 - Active, not recruiting
  Chronic Pain
  
• Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 gag DNA Alone or With IL-15 DNA) Given With or Without 3 Different Booster Vaccinations in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00115960 - Recruiting
  HIV Infections
  
• Function of Catecholamines in the Brain During Depression
  ClinicalTrials.gov Identifier: NCT00082030 - Active, not recruiting
  Depression; Involutional
  
• Screening Study of Surgery and CA 125 Levels in Participants at Increased Genetic Risk of Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00049049 - Active, not recruiting
  ovarian epithelial cancer
  
• A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Females Aged 15-25 Years.
  ClinicalTrials.gov Identifier: NCT00485732 - Active, not recruiting
  HPV-16 Infection; HPV-18 Infection; Associated Cervical Neoplasia
  
• Neurocardiac Control in Major Depression
  ClinicalTrials.gov Identifier: NCT00084162 - Active, not recruiting
  Depression, Involutional
  
• Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00002895 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• To assess the safety and tolerability of 7.5, 15 and 30 mg of sublingual lobeline. - 1
  ClinicalTrials.gov Identifier: NCT00100074 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Serotonin Function During Depression
  ClinicalTrials.gov Identifier: NCT00033787 - Active, not recruiting
  Depression, Involutional; Healthy
  
• Removal of the ovaries/fallopian tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
  ClinicalTrials.gov Identifier: NCT00043472 - Recruiting
  Ovarian Neoplasms; Breast Neoplasms
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Diphtheria, Tetanus & Pertussis Vaccine (DTaP) Vaccine & a Haemophilus Influenza Type B (Hib) Vaccine in Healthy Children 15 m of Age
  ClinicalTrials.gov Identifier: NCT00197236 - Active, not recruiting
  Hepatitis A
  
• Avonex 15 Year Long Term Follow-up Study
  ClinicalTrials.gov Identifier: NCT00525343 - Recruiting
  Multiple Sclerosis
  
• Randomized Study of Sildenafil Citrate During & After Radiotherapy for Erectile Ftn Vs Radiotherapy for Prostate Ca
  ClinicalTrials.gov Identifier: NCT00142506 - Recruiting
  Prostate Cancer
  
• UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide
  ClinicalTrials.gov Identifier: NCT00574080 - Recruiting
  Multiple Myeloma
  
• Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
  ClinicalTrials.gov Identifier: NCT00000350 - Active, not recruiting
  Amphetamine-Related Disorders; Tobacco Use Disorder
  
• Antibody Response and Immune Memory 15-18 Years After HBV Vaccination
  ClinicalTrials.gov Identifier: NCT00172328 - Recruiting
  Hepatitis B; Vaccine
  
• CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
  ClinicalTrials.gov Identifier: NCT00305838 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Molecular Targeting of 15-LOX-1 for Apoptosis Induction in Human Colorectal Cancers
  ClinicalTrials.gov Identifier: NCT00503035 - Recruiting
  Familial Adenomatous Polyposis
  
• Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®
  ClinicalTrials.gov Identifier: NCT00258856 - Active, not recruiting
  Meningitis; Meningococcal Infection
  
• 15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects.
  ClinicalTrials.gov Identifier: NCT00495729 - Recruiting
  Insomnia
  
• Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation
  ClinicalTrials.gov Identifier: NCT00310440 - Recruiting
  Degenerative Disc Disease (DDD); Decompresion of Spine Root
  
• Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
  ClinicalTrials.gov Identifier: NCT00550459 - Recruiting
  Hyponatremia
  
• Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003082 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Development of NIC5-15 in the Treatment of Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00470418 - Recruiting
  Alzheimer Disease; Dementia
  
• Positron Emission Tomography (PET) to Study Brain Signaling
  ClinicalTrials.gov Identifier: NCT00044200 - Recruiting
  Healthy
  
• Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults.
  ClinicalTrials.gov Identifier: NCT00528489 - Recruiting
  HIV Infections
  
• Safety, Tolerability and Immunogenicity of Quadrivalent Human Papillomavirus (HPV) Vaccine in Healthy Females 9 to 15 Years of Age in India
  ClinicalTrials.gov Identifier: NCT00380367 - Recruiting
  Papillomavirus Infections
  
• Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
  ClinicalTrials.gov Identifier: NCT00506415 - Recruiting
  Alzheimer Disease
  
• The Expression of IL-15 and Its Receptor in Decidua
  ClinicalTrials.gov Identifier: NCT00173758 - Recruiting
  Pregnancy; Infertility
  
• A 15-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00407745 - Recruiting
  Neuralgia; Spinal Cord Injuries
  
• The Use of Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) to Assess the Effects of Anti-Neoplastic Therapy on Tumor Associated Vasculature
  ClinicalTrials.gov Identifier: NCT00001709 - Recruiting
  Neoplasm
  
• Examination of Brain Serotonin Receptors in Patients with Mood Disorders
  ClinicalTrials.gov Identifier: NCT00026832 - Recruiting
  Mood Disorder
  
• Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines, Each Administered at 2, 4, 6, and 12 to 15 Months of Age.
  ClinicalTrials.gov Identifier: NCT00134719 - Active, not recruiting
  Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y.
  
• PET Scanning in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00024622 - Recruiting
  Parkinson Disease
  
• Studies of Frontal Lobe Brain Functioning in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00001258 - Recruiting
  Healthy; Schizophrenia
  
• Study of E7974 Given On Days 1, 8, and 15 of a 28-Day Cycle in Patients with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00121732 - Recruiting
  Neoplasms; Cancer
  
• Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00573469 - Recruiting
  Crohn's Disease
  
• Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients
  ClinicalTrials.gov Identifier: NCT00199979 - Recruiting
  Hiv Infection With Antiretroviral Therapy Indication; CD4 Below 350/µL or Below 15%
  
• SGN-15 And Docetaxel in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00031603 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age
  ClinicalTrials.gov Identifier: NCT00289913 - Recruiting
  Hepatitis A
  
• Brain Imaging in Depression
  ClinicalTrials.gov Identifier: NCT00050700 - Recruiting
  Depression; Bipolar Disorder
  
• ResQ Trial: Impact of an Impedance Threshold Device and Active Compression Decompression CPR on Survival from Out-of-Hospital Cardiac Arrest
  ClinicalTrials.gov Identifier: NCT00189423 - Recruiting
  Heart Arrest; Death, Sudden, Cardiac; Cardiopulmonary Resuscitation
  
• Erlotinib and Chemotherapy for Operable Stage IB-IIIA NSCLC Patients With Less Than or Equal 15 Pack Year Smoking History
  ClinicalTrials.gov Identifier: NCT00577707 - Recruiting
  Non Small Cell Lung Cancer; Lung Cancer; Clinical Stage IB-IIIA
  
• Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00450281 - Recruiting
  Lung Cancer
  
• Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00016159 - Active, not recruiting
  adult acute myeloid leukemia in remission; childhood acute myeloid leukemia in remission; adult acute promyelocytic leukemia (M3); ...
  
• 62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides
  ClinicalTrials.gov Identifier: NCT00469547 - Not yet recruiting
  Sexually Transmitted Infection
  
• Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00017342 - Active, not recruiting
  recurrent adult acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ...
  
• Tretinoin, Cytarabine, and Daunorubicin With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003934 - Active, not recruiting
  untreated adult acute myeloid leukemia; untreated childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00093600 - Active, not recruiting
  adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with inv(16)(p13;q22); ...
  
• GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00070551 - Active, not recruiting
  recurrent adult acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ...
  
• 17AAG to Treat Kidney Tumors in von Hippel-Lindau Disease
  ClinicalTrials.gov Identifier: NCT00088374 - Recruiting
  Hippel-Lindau Disease; Kidney Cancer
  
• A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours
  ClinicalTrials.gov Identifier: NCT00459823 - Not yet recruiting
  Cancer
  
• EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis
  ClinicalTrials.gov Identifier: NCT00142233 - Recruiting
  Hereditary Pancreatitis and idiopathic chronic pancreatitis
  
• Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00031187 - Completed
  Prostatic Neoplasms
  
• Effects of Roaccutane on Ca, P, PTH and Vitamin D Metabolites in the Treatment of Sever Acne
  ClinicalTrials.gov Identifier: NCT00416585 - Completed
  Acne
  
• Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)
  ClinicalTrials.gov Identifier: NCT00209404 - Completed
  Coronary Artery Disease
  
• Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00030355 - Recruiting
  recurrent childhood acute myeloid leukemia; recurrent adult acute myeloid leukemia; adult acute promyelocytic leukemia (M3); ...
  
• Phase III Randomized Study of UT-15 in Patients with Primary Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00004497 - Completed
  Pulmonary Hypertension
  
• FDG-PET to Investigate SGN-15 and Docetaxel in Patients with Advanced Non-Small Cell Lung Carcinoma
  ClinicalTrials.gov Identifier: NCT00086333 - Completed
  Non-Small Cell Lung Carcinoma
  
• A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
  ClinicalTrials.gov Identifier: NCT00053378 - Completed
  Hypocalcemia
  
• Effect of Direct Current Polarization on Brain Function
  ClinicalTrials.gov Identifier: NCT00088569 - Completed
  
  
• Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
  ClinicalTrials.gov Identifier: NCT00348400 - Completed
  Glaucoma
  
• Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes
  ClinicalTrials.gov Identifier: NCT00413751 - Completed
  Healthy
  
• Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
  ClinicalTrials.gov Identifier: NCT00073710 - Completed
  Secondary Hyperparathyroidism; Chronic Kidney Disease
  
• Dose-Finding Trial With Sugammadex at 3 and 15 Minutes After 1.0 and 1.2 mg/kg Rocuronium Bromide in Subjects of ASA Class 1-3
  ClinicalTrials.gov Identifier: NCT00535743 - Completed
  Anesthesia, General
  
• An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.
  ClinicalTrials.gov Identifier: NCT00426673 - Completed
  Epilepsy
  
• Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years
  ClinicalTrials.gov Identifier: NCT00383227 - Completed
  Hepatitis B